FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W2980518780> ?p ?o ?g. }

• W2980518780 endingPage "8989" @default.
• W2980518780 startingPage "8977" @default.
• W2980518780 abstract "Glioblastoma multiforme (GBM) is a highly malignant tumor of the central nervous system. Although primary GBM patients receive extensive therapies, tumors may recur within months, and there is no objective and scientific method to predict prognosis. Adoptive immunotherapy holds great promise for GBM treatment. However, the expression profiles of the tumor-associated antigens (TAAs) and tumor immune microenvironment (TME) genes used in immunotherapy of GBM patients have not been fully described. The present study aimed to develop a predictive tool to evaluate patient survival based on full analysis of the expression levels of TAAs and TME genes.Expression profiles of a panel of 87 TAAs and 8 TME genes significantly correlated with poor prognosis were evaluated in 44 GBM patients and 10 normal brain tissues using quantitative real-time polymerase chain reaction (qRT-PCR). A linear formula (the LASSO algorithm based in the R package) weighted by regression coefficients was used to develop a multi-element expression score to predict prognosis; this formula was cross-validated by the leave-one-out method in different GBM cohorts.After analysis of gene expression, clinical features, and overall survival (OS), a total of 8 TAAs (CHI3L1, EZH2, TRIOBP, PCNA, PIK3R1, PRKDC, SART3 and EPCAM), 1 TME gene (FOXP3) and 4 clinical features (neutrophil-to-lymphocyte (NLR), number of basophils (BAS), age and treatment with standard radiotherapy and chemotherapy) were included in the formula. There were significant differences between high and low scoring groups identified using the formula in different GBM cohorts (TCGA (n=732) and GEO databases (n=84)), implying poor and good prognosis, respectively.The multi-element expression score was significantly associated with OS of GBM patients. The improve understanding of TAAs and TMEs and well-defined formula could be implemented in immunotherapy for GBM to provide better care." @default.
• W2980518780 created "2019-10-25" @default.
• W2980518780 creator A5009570320 @default.
• W2980518780 creator A5023746467 @default.
• W2980518780 creator A5023826377 @default.
• W2980518780 creator A5024661134 @default.
• W2980518780 creator A5027872311 @default.
• W2980518780 creator A5030898881 @default.
• W2980518780 creator A5032122826 @default.
• W2980518780 creator A5035843064 @default.
• W2980518780 creator A5055144615 @default.
• W2980518780 creator A5057209439 @default.
• W2980518780 creator A5058850511 @default.
• W2980518780 creator A5069443238 @default.
• W2980518780 creator A5083216536 @default.
• W2980518780 date "2019-10-01" @default.
• W2980518780 modified "2023-10-16" @default.
• W2980518780 title "<p>A Multi-Element Expression Score Is A Prognostic Factor In Glioblastoma Multiforme</p>" @default.
• W2980518780 cites W1497855464 @default.
• W2980518780 cites W1828443506 @default.
• W2980518780 cites W1993463242 @default.
• W2980518780 cites W2020604769 @default.
• W2980518780 cites W2026419772 @default.
• W2980518780 cites W2030610701 @default.
• W2980518780 cites W2047599005 @default.
• W2980518780 cites W2050558251 @default.
• W2980518780 cites W2056678336 @default.
• W2980518780 cites W2059234749 @default.
• W2980518780 cites W2061590134 @default.
• W2980518780 cites W2066684749 @default.
• W2980518780 cites W2078461037 @default.
• W2980518780 cites W2081027784 @default.
• W2980518780 cites W2082226454 @default.
• W2980518780 cites W2087690546 @default.
• W2980518780 cites W2096287682 @default.
• W2980518780 cites W2101581271 @default.
• W2980518780 cites W2101653483 @default.
• W2980518780 cites W2104048484 @default.
• W2980518780 cites W2109107379 @default.
• W2980518780 cites W2111034570 @default.
• W2980518780 cites W2111578514 @default.
• W2980518780 cites W2112727616 @default.
• W2980518780 cites W2113038479 @default.
• W2980518780 cites W2114585110 @default.
• W2980518780 cites W2114843025 @default.
• W2980518780 cites W2133611748 @default.
• W2980518780 cites W2134807618 @default.
• W2980518780 cites W2136443603 @default.
• W2980518780 cites W2148977460 @default.
• W2980518780 cites W2149441684 @default.
• W2980518780 cites W2150032631 @default.
• W2980518780 cites W2150163498 @default.
• W2980518780 cites W2152064969 @default.
• W2980518780 cites W2157075165 @default.
• W2980518780 cites W2166101849 @default.
• W2980518780 cites W2329506722 @default.
• W2980518780 cites W2442246762 @default.
• W2980518780 cites W2518697037 @default.
• W2980518780 cites W2560012305 @default.
• W2980518780 cites W2891491540 @default.
• W2980518780 cites W2901658589 @default.
• W2980518780 cites W2920312376 @default.
• W2980518780 cites W2921471094 @default.
• W2980518780 cites W2989991684 @default.
• W2980518780 cites W583344130 @default.
• W2980518780 doi "https://doi.org/10.2147/cmar.s228174" @default.
• W2980518780 hasPubMedCentralId "https://www.ncbi.nlm.nih.gov/pmc/articles/6805247" @default.
• W2980518780 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/31695490" @default.
• W2980518780 hasPublicationYear "2019" @default.
• W2980518780 type Work @default.
• W2980518780 sameAs 2980518780 @default.
• W2980518780 citedByCount "6" @default.
• W2980518780 countsByYear W29805187802020 @default.
• W2980518780 countsByYear W29805187802022 @default.
• W2980518780 countsByYear W29805187802023 @default.
• W2980518780 crossrefType "journal-article" @default.
• W2980518780 hasAuthorship W2980518780A5009570320 @default.
• W2980518780 hasAuthorship W2980518780A5023746467 @default.
• W2980518780 hasAuthorship W2980518780A5023826377 @default.
• W2980518780 hasAuthorship W2980518780A5024661134 @default.
• W2980518780 hasAuthorship W2980518780A5027872311 @default.
• W2980518780 hasAuthorship W2980518780A5030898881 @default.
• W2980518780 hasAuthorship W2980518780A5032122826 @default.
• W2980518780 hasAuthorship W2980518780A5035843064 @default.
• W2980518780 hasAuthorship W2980518780A5055144615 @default.
• W2980518780 hasAuthorship W2980518780A5057209439 @default.
• W2980518780 hasAuthorship W2980518780A5058850511 @default.
• W2980518780 hasAuthorship W2980518780A5069443238 @default.
• W2980518780 hasAuthorship W2980518780A5083216536 @default.
• W2980518780 hasBestOaLocation W29805187801 @default.
• W2980518780 hasConcept C121608353 @default.
• W2980518780 hasConcept C126322002 @default.
• W2980518780 hasConcept C143998085 @default.
• W2980518780 hasConcept C147483822 @default.
• W2980518780 hasConcept C203014093 @default.
• W2980518780 hasConcept C2776107976 @default.
• W2980518780 hasConcept C2777389519 @default.
• W2980518780 hasConcept C2777701055 @default.

• next